Table 5.
Morbidity incidence rates by treatment group
|
Placebo |
Iron and folic acid |
Iron and folic acid with zinc |
---|---|---|---|
Diarrhoea | |||
Episodes | 1327 | 1355 | 1286 |
Person-years | 341.5 | 352.8 | 368.0 |
Rate/child per year | 3.89 | 3.84 | 3.50 |
RR (95% CI) | Ref | 0.94 (0.84−1.05) | 0.91 (0.81−1.01) |
Median (IQR) duration (days) | 2 (1−3) | 2 (1−3) | 2 (1−3) |
Persistent diarrhoea | |||
Episodes | 24 | 19 | 27 |
Person-years | 350.6 | 362.2 | 376.4 |
Rate/child per year | 0.069 | 0.053 | 0.072 |
RR (95% CI) | Ref | 0.74 (0.38−1.44) | 1.04 (0.56−1.91) |
Median (IQR) duration (days) | 18 (16−24) | 17 (16−19) | 18 (16−22) |
Dysentery | |||
Episodes | 187 | 166 | 164 |
Person-years | 349.6 | 361.4 | 376.0 |
Rate/child per year | 0.53 | 0.46 | 0.44 |
RR (95% CI) | Ref | 0.78 (0.57−1.09) | 0.85 (0.62−1.17) |
Median (IQR) duration (days) | 2 (1−3) | 2 (1−3) | 2 (1−3) |
Acute lower respiratory infection | |||
Episodes | 481 | 482 | 461 |
Person-years | 347.6 | 358.6 | 373.3 |
Rate/child per year | 1.38 | 1.34 | 1.23 |
RR (95% CI) | Ref | 0.92 (0.77−1.09) | 0.91 (0.76−1.08) |
Median (IQR) duration (days) | 3 (2−4) | 3 (2−4) | 3 (2−4) |